Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

RNXT - RenovoRx, Inc. Stock Price, Fair Value and News

$0.98+0.03 (+3.16%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

RNXT Price Action

Last 7 days

4.3%

Last 30 days

-18.3%

Last 90 days

-30%

Trailing 12 Months

-4.9%

RNXT RSI Chart

Dec2025FebMarAprMayJunJulAug102030405060708090

RNXT Valuation

Market Cap

35.9M

Price/Earnings (Trailing)

-3.37

Price/Sales (Trailing)

1.1K

Price/Free Cashflow

-4.4

RNXT Price/Sales (Trailing)

2025FebMarAprMayJunJulAug5006007008009001K1.1K1.2K

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

RNXT Fundamentals

RNXT Revenue

Revenue (TTM)

43.0K

JulOct2025Apr43K

RNXT Earnings

Earnings (TTM)

-10.7M

Earnings Growth (Yr)

-21.18%

Earnings Growth (Qtr)

-19.63%

20212022202320242025-10M-8M-6M-4M

RNXT Profitability

Return on Equity

-100.22%

Return on Assets

-78.16%

Free Cashflow Yield

-22.71%

RNXT Investor Care

Shares Dilution (1Y)

52.78%

Diluted EPS (TTM)

-0.38

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Dec43K
Net sales
YearQ1Q2Q3Q4
20250000
202400043.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About RenovoRx, Inc.

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. The company was founded in 2009 and is headquartered in Los Altos, California.
 CEO
 WEBSITEhttps://renovorx.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES10

RenovoRx, Inc. Frequently Asked Questions

What is the ticker symbol for RenovoRx, Inc.? What does RNXT stand for in stocks?

RNXT is the stock ticker symbol of RenovoRx, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of RenovoRx, Inc. (RNXT)?

As of Fri Aug 29 2025, market cap of RenovoRx, Inc. is 35.91 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of RNXT stock?

You can check RNXT's fair value in chart for subscribers.

Is RenovoRx, Inc. a good stock to buy?

The fair value guage provides a quick view whether RNXT is over valued or under valued. Whether RenovoRx, Inc. is cheap or expensive depends on the assumptions which impact RenovoRx, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RNXT.

What is RenovoRx, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Aug 29 2025, RNXT's PE ratio (Price to Earnings) is -3.37 and Price to Sales (PS) ratio is 1.06 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RNXT PE ratio will change depending on the future growth rate expectations of investors.